References
- Hasan DA, Maulud SQ, Jalal PJ, Priyanka, Choudhary OP. SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: a case report. Hum Vacc Immunother. 2022 Apr 14:1–3.
- UK Office for National Statistics. Coronavirus (COVID-19) infection survey, characteristics of people testing positive for COVID-19, UK: 19 January 2022 [Internet]; 2022 [accessed 2022 Jan 21]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveycharacteristicsofpeopletestingpositiveforcovid19uk/latest#reinfections-withcovid-19-uk.
- Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27(3):315–18. doi:10.1016/j.cmi.2020.11.028.
- Choudhary ML, Vipat V, Jadhav S, Basu A, Cherian S, Abraham P, Potdar V. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV2 in India. Ind J Med Res. 2020;151(2):251. doi:10.4103/ijmr.IJMR_671_20.
- Yadav PD, Nyayanit DA, Shete AM, Jain S, Majumdar TP, Chaubal GY, Shil P, Kore PM, Mourya DT. Complete genome sequencing of Kaisodi virus isolated from ticks in India belonging to Phlebovirus genus, family Phenuiviridae. Ticks Tick Borne Dis. 2019;10(1):23–33. doi:10.1016/j.ttbdis.2018.08.012.
- Deshpande G, Kaduskar O, Deshpande K, Bhatt V, Yadav P, Gurav Y, Potdar V, Khutwad K, Vidhate S, Salunke A, et al. Longitudinal clinic-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2. Int J Infect Dis. 2021;112:103–10. doi:10.1016/j.ijid.2021.09.024.
- Deshpande GR, Sapkal GN, Tilekar BN, Yadav P, Gurav Y, Gaikwad S, Kaushal H, Deshpande K, Kaduskar O, Sarkale P, et al. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Ind J Med Res. 2020 July;152(1):82. doi:10.4103/ijmr.IJMR_2382_20.